Evidence map›Paper›PMID 21847442›Full record

ArticleJRSM short reports2011

Comparing the USA, UK and 17 Western countries' efficiency and effectiveness in reducing mortality.

Colin Pritchard, Mark S Wallace

Abstract read
In one paragraph

Article in JRSM short reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The financial performance of the health care industry: a global, regional and industry specific empirical investigation.The European journal of health economics : HEPAC : health economics in prevention and care · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Rate of improvement of CF life expectancy exceeds that of general population--observational death registration study.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2014
    Observational
  9. Article
  10. Article
  11. Article
  12. Opening the oyster: the 2010-11 NHS reforms in England.Clinical medicine (London, England) · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Colin PritchardSchool of Health & Social Care, Bournemouth University , Bournemouth , UK.
Mark S Wallace

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo test the hypothesis that the USA healthcare system was superior to the NHS and 17 other Western countries in reducing feasible mortality rates over the period 1979-2005.

designEconomic inputs into healthcare, GDP health expenditure (GDPHE) were compared with clinical outputs, i.e. total 'adult' (15-74 years) and 'older' (55-74 years) mortality rates based upon three-year average mortality rates for 1979-81 vs. 2003-2005. A cost-effective ratio was calculated by dividing average GDPHE into reduced mortality rates over the period.

settingNineteen Western countries' mortality rates compared between 1979-2005.

participantsMortality of people by age and gender.

main outcome measuresA cost-effective ratio to measure efficiency and effectiveness of healthcare systems in reducing mortality rates. Chi-square tested any differences between the USA, UK and other Western countries.

resultsINPUT: The USA had the highest current and average GDPHE; the UK was 10th highest but joint 16th overall, still below the Western countries' average. Output: Every country's mortality rate fell substantially; but 15 countries reduced their mortality rates significantly more than the US, while UK 'adult' and 'older' mortality rates fell significantly more than 12 other countries. Cost-effectiveness: The USA GDPHE: mortality rate ratio was 1:205 for 'adults' and 1:515 for 'older' people, 16 Western countries having bigger ratios than the US; the UK had second greatest ratios at 1:593 and 1:1595, respectively. The UK ratios were >20% larger than 14 other countries.

conclusionsIn cost-effective terms, i.e. economic input versus clinical output, the USA healthcare system was one of the least cost-effective in reducing mortality rates whereas the UK was one of the most cost-effective over the period.

Identifiers

PMID21847442
PMCPMC3147241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.